個股熱度排行 | 5月4日港股收盤
根據uSMART輿情監測數據,4日港股交易時段,市場關注指數最高的2只股票是京東健康、中國中鐵。
5月4日—港股關注排行TOP2

京東健康

關注度第一爲京東健康,該股今日收盤下跌12.97%,報於43.60港元。近5個交易日累計下跌4.07%。在消息面和社交媒體方面,輿情以看空爲主。較被市場關注的消息有:
京東健康挫近5% 遭創辦人劉強東兩度減持884.04萬股
京東健康跌幅擴至14% 遭大股東劉強東減持共套近4.4億元
中國中鐵

關注度第二爲中國中鐵,該股今日收盤上漲3.20%,報於5.81港元。近5個交易日累計上漲15.97%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:
中國中鐵創52周內新高 交銀將其目標價上調21.7%至6.45港元
港股有3只股票創新高,中國中鐵大漲3.2%,近一年漲幅達59.35%
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.